File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Chronic ketamine abuse causes dysfunctions of different brain areas relevant to neurodevelopmental psychiatric disorders: evidence from fMRI in a primate model

TitleChronic ketamine abuse causes dysfunctions of different brain areas relevant to neurodevelopmental psychiatric disorders: evidence from fMRI in a primate model
Authors
KeywordsPharmacy and pharmacology psychology
Issue Date2010
PublisherCambridge University Press. The Journal's web site is located at http://journals.cambridge.org/action/displayJournal?jid=PNP
Citation
The 27th International College of NeuroPsychopharmacology (CINP) Congress, Hong Kong, China, 6-10 June 2010. In International Journal of Neuropsychopharmacology, 2010, v. 13 suppl. S1, p. 58, abstract no. P-01.046 How to Cite?
AbstractOBJECTIVE: Ketamine is a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist, and illegal use of it as a recreational drug among adolescence and young adult is rapidly growing. Many studies have showed that prefrontal dopaminergic system is particularly vulnerable to the toxic effects on cognitive functions. This suggests that chronic ketamine abuse in young people may cause a severe disruption of different brain areas relevant to psychiatric disorders. METHODS: We established a chronic ketamine abuse model using the adolescent cynomoglus monkeys administrated with ketamine once a day (1 mg/kg, i.v.) for 6 months. Blood oxygenation level dependent (BOLD) contrast images were generated through stimulating the function of somatosensory area using functional magnetic resonance imaging (fMRI). Parallel and successive behavioral were observed. RESULTS: Chronic ketamine abuse in younger monkeys caused obvious deficits in the ventral tegmental area (VTA)/substantial nigra (SN), parietal cortex, and cingulate cortex. Besides, some increased activities were observed in striatum (lentiform nucleus, LN), fusiform gyrus (FG) and entorhinal cortex (Ent) on the right side of the brain in the chronic ketamine administrated monkeys. Behaviour results showed significant differences of the movement in both control and ketamine groups with general and consistent decreased trend with time periods of ketamine administration. CONCLUSION: Dysfunction of a projection from Ent to LN could play a role in ketamine abuse or induce epilepsy. We also found that deficit of cortical visual area in ketamine abuse model might cause a ‘positive schizophrenic syndrome’. Moreover, hypofunction of mesocortical dopamine pathway may induce a negative symptom in psychosis, or attention deficit disorder (ADD).
DescriptionThis journal supplement has title: Abstracts from the XXVII CINP Congress, Hong Kong, 6–10 June 2010
Poster Session - P-01. Addictive Disorders
Persistent Identifierhttp://hdl.handle.net/10722/146637
ISSN
2023 Impact Factor: 4.5
2023 SCImago Journal Rankings: 1.525

 

DC FieldValueLanguage
dc.contributor.authorYu, HL-
dc.contributor.authorLi, Q-
dc.contributor.authorWong, DF-
dc.contributor.authorShi, L-
dc.contributor.authorMak, YT-
dc.contributor.authorLu, G-
dc.contributor.authorShun, L-
dc.contributor.authorWang, L-
dc.contributor.authorCheng, M-
dc.contributor.authorPan, F-
dc.contributor.authorYew, DT-
dc.date.accessioned2012-05-08T08:50:41Z-
dc.date.available2012-05-08T08:50:41Z-
dc.date.issued2010-
dc.identifier.citationThe 27th International College of NeuroPsychopharmacology (CINP) Congress, Hong Kong, China, 6-10 June 2010. In International Journal of Neuropsychopharmacology, 2010, v. 13 suppl. S1, p. 58, abstract no. P-01.046-
dc.identifier.issn1461-1457-
dc.identifier.urihttp://hdl.handle.net/10722/146637-
dc.descriptionThis journal supplement has title: Abstracts from the XXVII CINP Congress, Hong Kong, 6–10 June 2010-
dc.descriptionPoster Session - P-01. Addictive Disorders-
dc.description.abstractOBJECTIVE: Ketamine is a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist, and illegal use of it as a recreational drug among adolescence and young adult is rapidly growing. Many studies have showed that prefrontal dopaminergic system is particularly vulnerable to the toxic effects on cognitive functions. This suggests that chronic ketamine abuse in young people may cause a severe disruption of different brain areas relevant to psychiatric disorders. METHODS: We established a chronic ketamine abuse model using the adolescent cynomoglus monkeys administrated with ketamine once a day (1 mg/kg, i.v.) for 6 months. Blood oxygenation level dependent (BOLD) contrast images were generated through stimulating the function of somatosensory area using functional magnetic resonance imaging (fMRI). Parallel and successive behavioral were observed. RESULTS: Chronic ketamine abuse in younger monkeys caused obvious deficits in the ventral tegmental area (VTA)/substantial nigra (SN), parietal cortex, and cingulate cortex. Besides, some increased activities were observed in striatum (lentiform nucleus, LN), fusiform gyrus (FG) and entorhinal cortex (Ent) on the right side of the brain in the chronic ketamine administrated monkeys. Behaviour results showed significant differences of the movement in both control and ketamine groups with general and consistent decreased trend with time periods of ketamine administration. CONCLUSION: Dysfunction of a projection from Ent to LN could play a role in ketamine abuse or induce epilepsy. We also found that deficit of cortical visual area in ketamine abuse model might cause a ‘positive schizophrenic syndrome’. Moreover, hypofunction of mesocortical dopamine pathway may induce a negative symptom in psychosis, or attention deficit disorder (ADD).-
dc.languageeng-
dc.publisherCambridge University Press. The Journal's web site is located at http://journals.cambridge.org/action/displayJournal?jid=PNP-
dc.relation.ispartofInternational Journal of Neuropsychopharmacology-
dc.rightsInternational Journal of Neuropsychopharmacology. Copyright © Cambridge University Press.-
dc.subjectPharmacy and pharmacology psychology-
dc.titleChronic ketamine abuse causes dysfunctions of different brain areas relevant to neurodevelopmental psychiatric disorders: evidence from fMRI in a primate modelen_US
dc.typeConference_Paperen_US
dc.identifier.emailLi, Q: liqi@hkucc.hku.hk-
dc.identifier.emailYew, DT: david-yew@cuhk.edu.hk-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1017/S1461145710000635-
dc.identifier.hkuros175908-
dc.identifier.volume13-
dc.identifier.issuesuppl. S1-
dc.identifier.spage58-
dc.identifier.epage58-
dc.publisher.placeUnited Kingdom-
dc.description.otherThe 27th International College of NeuroPsychopharmacology (CINP) Congress, Hong Kong, China, 6-10 June 2010. In International Journal of Neuropsychopharmacology, 2010, v. 13 suppl. S1, p. 58, abstract no. P-01.046-
dc.identifier.issnl1461-1457-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats